Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;102(12):e490-e493.
doi: 10.3324/haematol.2016.162925. Epub 2017 Sep 21.

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

Affiliations

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

Susan L Heatley et al. Haematologica. 2017 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Children with Ph-like ALL have inferior survival outcomes compared to other B-ALL patients. Kaplan-Meier analysis with log-rank statistic of A) event free survival and B) overall survival at five years post diagnosis. Children with Ph-like ALL are shown in red, BCR-ABL1+ patients in orange, ETV6-RUNX1 in green and the remaining BALL children in blue. The number of patients at risk for the different B-ALL subtypes is shown below the graph at each year.

References

    1. Pui CH, Pei D, Campana D, et al. A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia. 2014; 28(12):2336–2343. - PMC - PubMed
    1. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360(5):470–480. - PMC - PubMed
    1. Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125–134. - PMC - PubMed
    1. Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2):153–166. - PMC - PubMed
    1. Marshall GM, Dalla Pozza L, Sutton R, et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. 2013;27(7):1497–1503. - PubMed

Publication types

LinkOut - more resources